{"id":"W4306399353","doi":"10.1002/ejhf.2720","title":"Soluble guanylate cyclase stimulators in patients with heart failure with reduced ejection fraction across the risk spectrum","year":2022,"lang":"en","type":"review","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"National Heart, Lung, and Blood Institute; Relypsa; National Medical Research Council; Medical Research Council; Respicardia; American Regent; National Institutes of Health; Daiichi Sankyo Europe; Abbott Diagnostics; Bayer; Gilead Sciences; Servier; MyoKardia; Novo Nordisk; Impulse Dynamics; Cytokinetics; Boston Scientific Corporation; Bayer HealthCare; Lantheus Medical Imaging; Patient-Centered Outcomes Research Institute; LivaNova; GlaxoSmithKline; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Vifor Pharma; Pfizer; Edwards Lifesciences; Amgen; Sanofi; Abbott Laboratories; American Heart Association","keywords":"Medicine; Heart failure; GUCY1A3; Ejection fraction; Cardiology; Guanylate cyclase; Internal medicine; GUCY1B3; Guanylate cyclase 2C; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00125309,0.0004064006,0.001489467,0.0008477278,0.0001355667,0.0007129177,0.0004451215,0.0006481027,0.001218771],"category_scores_gemma":[0.001927026,0.0001411106,0.000938796,0.0007672086,0.0002058974,0.0005962179,0.0002841094,0.0008873242,0.0002629627],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003043384,"about_ca_system_score_gemma":0.0007935136,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007946789,"about_ca_topic_score_gemma":0.002187587,"domain_scores_codex":[0.9994295,0.0002267516,0.0001503502,0.00006847086,0.0000966353,0.0000282252],"domain_scores_gemma":[0.9991085,0.0006084556,0.0001410363,0.00001160275,0.0001030151,0.00002743063],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005140392,0.000067223,0.001253179,0.0647454,0.0007594498,0.0001985622,0.0001298033,0.0002452356,0.001506824,0.001608867,0.01039566,0.9185757],"study_design_scores_gemma":[0.0009386404,0.003126708,0.02462585,0.09387117,0.007646117,0.003753375,0.0005056752,0.0007071129,0.002354933,0.004995907,0.8573666,0.0001078639],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003643691,0.9988624,0.00005121153,0.0003219168,0.00010179,0.000007388205,0.00001439832,0.000001797623,0.0002746746],"genre_scores_gemma":[0.003971579,0.9948676,0.0002382474,0.0004504941,0.0002676765,0.00002361141,0.00002866196,0.00000108096,0.0001510716],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.001489467,"threshold_uncertainty_score":0.006627023,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01747477405645493,"score_gpt":0.2781897477173685,"score_spread":0.2607149736609136,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}